LANGERHANS CELL HISTIOCYTOSIS
Clinical trials for LANGERHANS CELL HISTIOCYTOSIS explained in plain language.
Never miss a new study
Get alerted when new LANGERHANS CELL HISTIOCYTOSIS trials appear
Sign up with your email to follow new studies for LANGERHANS CELL HISTIOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare immune disease: targeted drug trial launches
Disease control Recruiting nowThis study tests a drug called trametinib in 75 children with Langerhans cell histiocytosis (LCH), a rare disease where immune cells grow out of control. The goal is to see if the drug is safe and can stop the disease from getting worse. Children who are newly diagnosed or whose …
Matched conditions: LANGERHANS CELL HISTIOCYTOSIS
Phase: PHASE2 • Sponsor: Cook Children's Health Care System • Aim: Disease control
Last updated May 17, 2026 03:18 UTC
-
New combo therapy aims to control rare immune disease in adults
Disease control Recruiting nowThis study tests a combination of two drugs, low-dose cytarabine and thalidomide, in 50 adults with untreated Langerhans cell histiocytosis (LCH), a rare disease where immune cells build up and damage tissues. The goal is to see if this treatment can stop the disease from getting…
Matched conditions: LANGERHANS CELL HISTIOCYTOSIS
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New hope for kids with rare cancer: could one drug beat the standard?
Disease control Recruiting nowThis study tests whether a single chemotherapy drug, cytarabine, works better than the usual two-drug combination (vinblastine/prednisone) for treating Langerhans cell histiocytosis (LCH), a rare cancer that causes tissue damage. About 124 children and young adults up to age 21 w…
Matched conditions: LANGERHANS CELL HISTIOCYTOSIS
Phase: PHASE3 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 05, 2026 11:55 UTC